|
|
| | Penicillin V Potassium-d5 Basic information |
| | Penicillin V Potassium-d5 Chemical Properties |
| solubility | PBS (pH 7.2): 10 mg/ml | | form | A solid | | color | White to off-white |
| | Penicillin V Potassium-d5 Usage And Synthesis |
| Description | Penicillin V-d5 is intended for use as an internal standard for the quantification of penicillin V by GC- or LC-MS. Penicillin V is a β-lactam antibiotic that inhibits the growth of bacteria.1,2,3 In vitro, penicillin V inhibits the growth of clinical isolates of Streptococci (MICs = 0.004-0.008 mg/L) and C. difficile (MICs = 1 to >256 mg/L).1,2 Penicillin V also inhibits growth of S. aureus in vitro (MIC = 0.016 mg/L) and in vivo in a thigh model of infection in mice.3 It inhibits the growth of S. pyogenes in mice following one or two dose therapy with curative dose (CD50) values of 0.207 and 0.031 mg, respectively.4 Penicillin V (100 mg/kg per day, p.o.) prevents experimental acute otitis media in rats when administered prior to infection by pneumococci.5 Formulations containing penicillin V have been used to treat bacterial infections of the skin, throat, ear, mouth, and respiratory tract. | | Uses | Penicillin V-d5 (potassium) is the deuterium labeled Penicillin V Potassium[1]. Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) is an orally active antibiotic. Penicillin V Potassium inhibits the growth of Streptococci, C. difficile and S. aureus. Penicillin V Potassium can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis[2][3][4][5]. | | References | 1. Kamme, C., and Petersson, A.C. In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V Scand. J. Infect. Dis. 25(1),37-42(1993).
2. Norén, T., Alriksson, I., Akerlund, T., et al. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden Clin. Microbiol. Infect. 16(8),1104-1110(2010).
3. Overbosch, D., Mattie, H., and Van Furth, R. Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin Br. J. Clin. Pharmacol. 19(5),657-668(1985).
4. Powell, H.M., and Culbertson, C.G. Effectiveness of phenoxymethyl penicillin V, and sodium penicillin G against hemolytic Streptococcus infection in white mice Proc. Soc. Exp. Biol. Med. 90(1),186-187(1955).
5. Hermansson, A., Prellner, K., and Hellstrm, S. Prevention of experimental acute otitis media with penicillin V Acta Otolaryngol. 109(1-2),119-123(1990). |
| | Penicillin V Potassium-d5 Preparation Products And Raw materials |
|